Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
Authors
Keywords
-
Journal
VACCINE
Volume 40, Issue 40, Pages 5798-5805
Publisher
Elsevier BV
Online
2022-08-31
DOI
10.1016/j.vaccine.2022.08.036
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BNT162b2 Vaccine‐Associated Myo/Pericarditis in Adolescents: A Stratified Risk‐Benefit Analysis
- (2022) Allison Krug et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Covid-19 vaccines and treatments: we must have raw data, now
- (2022) Peter Doshi et al. BMJ-British Medical Journal
- Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States
- (2022) Diego Montano Frontiers in Public Health
- Is the Harm-to-Benefit Ratio a Key Criterion in Vaccine Approval?
- (2022) Falk Mörl et al. Frontiers in Medicine
- Evidence-based medicine has already adapted and is very much alive
- (2022) Mohammad Hassan Murad et al. BMJ Evidence-Based Medicine
- Adapt or die: how the pandemic made the shift from EBM to EBM+ more urgent
- (2022) Trisha Greenhalgh et al. BMJ Evidence-Based Medicine
- General determination of causation between Covid-19 vaccines and possible adverse events
- (2021) Lee M. Hampton et al. VACCINE
- Dealing with the Inevitable Deficiencies of Bias Analysis – and All Analyses
- (2021) Sander Greenland AMERICAN JOURNAL OF EPIDEMIOLOGY
- SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2
- (2021) Yuyang Lei et al. CIRCULATION RESEARCH
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Importance of Making Assumptions in Bias Analysis
- (2021) Richard F. MacLehose et al. EPIDEMIOLOGY
- Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
- (2021) Noam Barda et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
- (2021) Xintong Li et al. BMJ-British Medical Journal
- Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database
- (2021) Rimple Kaur et al. International Journal of General Medicine
- Transparency of COVID-19 vaccine trials: decisions without data
- (2021) Sarah Tanveer et al. BMJ Evidence-Based Medicine
- Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older
- (2021) Marie Joelle Jabagi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
- (2021) Martina Patone et al. NATURE MEDICINE
- Extrapulmonary manifestations of COVID-19
- (2020) Aakriti Gupta et al. NATURE MEDICINE
- Semantic and cognitive tools to aid statistical science: replace confidence and significance by compatibility and surprise
- (2020) Zad Rafi et al. BMC Medical Research Methodology
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Scientists rise up against statistical significance
- (2019) Valentin Amrhein et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started